An Open Label, Multi Centre, Phase II Study to Evaluate the Safety and Efficacy of Coramsine Injection in Patients with Melanoma
An Open Label, Multi Centre, Phase II Study to Evaluate the Safety and Efficacy of Coramsine Injection in Patients with Renal Cell Carcinoma
100 Clinical Results associated with Solbec Pharmaceuticals Ltd.
0 Patents (Medical) associated with Solbec Pharmaceuticals Ltd.
100 Deals associated with Solbec Pharmaceuticals Ltd.
100 Translational Medicine associated with Solbec Pharmaceuticals Ltd.